Cardiovascular Risk Factor Clinical Trial
Official title:
Effect of an Aerobic Exercise Program Associated With Shock Wave Therapy Versus Radiofrequency on Skin and Subcutaneous Tissue: Randomized Controlled Study
NCT number | NCT04282057 |
Other study ID # | AN-009 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | February 22, 2020 |
Est. completion date | June 19, 2020 |
Verified date | September 2020 |
Source | Escola Superior de Tecnologia da Saúde do Porto |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main objective of this study is to compare the effect of 6 sessions of shock wave therapy versus radiofrequency followed by a protocol of moderate aerobic exercise, in the reduction of adiposity and abdominal flaccidity, in females between 18 and 60 years old. As a secondary objective, it is intended to understand the mechanism of fat mobilization by these two therapies.
Status | Completed |
Enrollment | 30 |
Est. completion date | June 19, 2020 |
Est. primary completion date | April 25, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Women aged 18 to 60 years Exclusion Criteria: - smoking and drinking habits; - athletes; - people with dietary restrictions; - participants who have had diets to lose weight in the last 3 months or who will start during the study; - pregnant women; - in postpartum less than one year; - breastfeeding; - intending to become pregnant during the study period; - patients with electronic or metallic devices (pacemaker, IUD); - individuals with metabolic (including dyslipidemias); - hematological and renal disorders; - individuals with dermatological changes; - cardiovascular, respiratory, digestive, orthopedic, rheumatological and oncological pathologies; - changes in the immune system or with acute inflammatory processes; - changes in sensitivity or subject to medication (anti-coagulants, corticosteroids up to 6 weeks before, non-steroidal anti-inflammatory drugs, antihistamines, diuretics) |
Country | Name | City | State |
---|---|---|---|
Portugal | Andreia Noites | Vila Nova de Gaia | Porto |
Lead Sponsor | Collaborator |
---|---|
Escola Superior de Tecnologia da Saúde do Porto |
Portugal,
Adatto MA, Adatto-Neilson R, Novak P, Krotz A, Haller G. Body shaping with acoustic wave therapy AWT(®)/EPAT(®): randomized, controlled study on 14 subjects. J Cosmet Laser Ther. 2011 Dec;13(6):291-6. doi: 10.3109/14764172.2011.630089. — View Citation
Modena DAO, da Silva CN, Grecco C, Guidi RM, Moreira RG, Coelho AA, Sant'Ana E, de Souza JR. Extracorporeal shockwave: mechanisms of action and physiological aspects for cellulite, body shaping, and localized fat-Systematic review. J Cosmet Laser Ther. 2017 Oct;19(6):314-319. doi: 10.1080/14764172.2017.1334928. Epub 2017 Jun 7. Review. — View Citation
Noites A, Vale AL, Pereira AS, Morais A, Vilarinho R, Carvalho P, Amorim M, Moreira T, Mendonça A. Effect of an aerobic exercise session combined with abdominal radiofrequency on lipolytic activity in women: Randomized control trial. J Cosmet Dermatol. 2020 Mar;19(3):638-645. doi: 10.1111/jocd.13056. Epub 2019 Jun 29. — View Citation
Vale AL, Pereira AS, Morais A, de Carvalho P, Vilarinho R, Mendonça A, Noites A. Effect of four sessions of aerobic exercise with abdominal radiofrequency in adipose tissue in healthy women: Randomized control trial. J Cosmet Dermatol. 2020 Feb;19(2):359-367. doi: 10.1111/jocd.13036. Epub 2019 Jun 3. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cutaneous abdominal tissue thickness | Measurement of the cutaneous fold by ultrasonography | Baseline | |
Primary | Cutaneous abdominal tissue thickness | Measurement of the cutaneous fold by ultrasonography | 3 weeks after | |
Primary | Cutaneous abdominal tissue thickness | Measurement of the cutaneous fold by ultrasonography | 6 weeks after | |
Primary | Subcutaneous abdominal tissue thickness | Measurement of the subcutaneous adipose fold by ultrasonography | Baseline | |
Primary | Subcutaneous abdominal tissue thickness | Measurement of the subcutaneous adipose fold by ultrasonography | 3 weeks after | |
Primary | Subcutaneous abdominal tissue thickness | Measurement of the subcutaneous adipose fold by ultrasonography | 6 weeks after | |
Primary | Glycerol concentration | Blood analysis collection carried out with help from an clinical analysis technician | Baseline | |
Primary | Glycerol concentration | Blood analysis collection carried out with help from an clinical analysis technician | 3 weeks after | |
Primary | Glycerol concentration | Blood analysis collection carried out with help from an clinical analysis technician | 6 weeks after | |
Primary | Lipid profile (LDL, HDL and triglyceride concentrations) | Blood analysis collection carried out with help from an clinical analysis technician | Baseline | |
Primary | Lipid profile (LDL, HDL and triglyceride concentrations) | Blood analysis collection carried out with help from an clinical analysis technician | 3 weeks after | |
Primary | Lipid profile (LDL, HDL and triglyceride concentrations) | Blood analysis collection carried out with help from an clinical analysis technician | 6 weeks after | |
Primary | Perimetry | Perimetry consists of measuring circumferences. In this case, of the waist at the navel area, 3 cm below it and in the hip area | Baseline | |
Primary | Perimetry | Perimetry consists of measuring circumferences. In this case, of the waist at the navel area, 3 cm below it and in the hip area | 3 weeks after | |
Primary | Perimetry | Perimetry consists of measuring circumferences. In this case, of the waist at the navel area, 3 cm below it and in the hip area | 6 weeks after | |
Primary | Adipometry | Adipometry consists of measuring skinfold thickness | Baseline | |
Primary | Adipometry | Adipometry consists of measuring skinfold thickness | 3 weeks after | |
Primary | Adipometry | Adipometry consists of measuring skinfold thickness | 6 weeks after | |
Primary | Inflammatory markers concentration (IL6, CRP, TNF) | Blood analysis collection carried out with help from an clinical analysis technician | Baseline | |
Primary | Inflammatory markers concentration (IL6, CRP, TNF) | Blood analysis collection carried out with help from an clinical analysis technician | 3 weeks after | |
Primary | Inflammatory markers concentration (IL6, CRP, TNF) | Blood analysis collection carried out with help from an clinical analysis technician | 6 weeks after | |
Primary | Nitrous oxide concentration | Blood analysis collection carried out with help from an clinical analysis technician | Baseline | |
Primary | Nitrous oxide concentration | Blood analysis collection carried out with help from an clinical analysis technician | 3 weeks after | |
Primary | Nitrous oxide concentration | Blood analysis collection carried out with help from an clinical analysis technician | 6 weeks after | |
Primary | Body composition- body mass | body mass in kilograms | Baseline | |
Primary | Body composition- body mass | body mass in kilograms | 3 weeks after | |
Primary | Body composition- body mass | body mass in kilograms | 6 weeks after | |
Primary | Body composition- muscle mass | muscle mass in kilograms | Baseline | |
Primary | Body composition- muscle mass | muscle mass in kilograms | 3 weeks after | |
Primary | Body composition- muscle mass | muscle mass in kilograms | 6 weeks after | |
Primary | Body composition- fat mass | fat mass in kilograms | Baseline | |
Primary | Body composition- fat mass | fat mass in kilograms | 3 weeks after | |
Primary | Body composition- fat mass | fat mass in kilograms | 6 weeks after | |
Primary | Body composition- visceral fat | visceral fat | Baseline | |
Primary | Body composition- visceral fat | visceral fat | 3 weeks after | |
Primary | Body composition- visceral fat | visceral fat | 6 weeks after | |
Primary | Body composition- fat body areas | percentage of fat distributed by body areas | Baseline | |
Primary | Body composition- fat body areas | percentage of fat distributed by body areas | 3 weeks after | |
Primary | Body composition- fat body areas | percentage of fat distributed by body areas | 6 weeks after | |
Primary | Thermography | Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome | Baseline | |
Primary | Thermography | Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome | 3 weeks after | |
Primary | Thermography | Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome | 6 weeks after | |
Primary | Photography | Photography is used to compare the before and after images. With these it is possible to evaluate the skin flaccidity and fat | Baseline | |
Primary | Photography | Photography is used to compare the before and after images. With these it is possible to evaluate the skin flaccidity and fat | 3 weeks after | |
Primary | Photography | Photography is used to compare the before and after images. With these it is possible to evaluate the skin flaccidity and fat | 6 weeks after | |
Secondary | skin flaccidity | Investigator Assessment Skin Laxity Scoring System - Questionnaire that evaluates skin flaccidity and scores from 0 to 4. (As the subjectivity assessment of this outcome, the investigator who evaluates is blind to the group that the participants are allocated, in order to avoid partial scores) | Baseline | |
Secondary | skin flaccidity | Investigator Assessment Skin Laxity Scoring System - Questionnaire that evaluates skin flaccidity and scores from 0 to 4. (As the subjectivity assessment of this outcome, the investigator who evaluates is blind to the group that the participants are allocated, in order to avoid partial scores) | 3 weeks after | |
Secondary | skin flaccidity | Investigator Assessment Skin Laxity Scoring System - Questionnaire that evaluates skin flaccidity and scores from 0 to 4. (As the subjectivity assessment of this outcome, the investigator who evaluates is blind to the group that the participants are allocated, in order to avoid partial scores) | 6 weeks after | |
Secondary | skin flaccidity and localized fat in the abdomen region | Satisfaction questionnaire to evaluate the final results according to the participant | Baseline | |
Secondary | skin flaccidity and localized fat in the abdomen region | Satisfaction questionnaire to evaluate the final results according to the participant | 3 weeks after | |
Secondary | skin flaccidity and localized fat in the abdomen region | Satisfaction questionnaire to evaluate the final results according to the participant | 6 weeks after |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04481503 -
Transthoracic Echocardiography of Ventricular Function of Parturients in Labor
|
||
Terminated |
NCT04088240 -
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
|
N/A | |
Completed |
NCT03410342 -
The Effects of Types of Fruits and Vegetables on Vascular Function
|
N/A | |
Completed |
NCT03170752 -
Implementing and Testing a Cardiovascular Assessment Screening Program (CASP)
|
N/A | |
Recruiting |
NCT04231838 -
Metabolic Syndrome in Diabetic Smokers Using Cigarettes & Combustion-Free Nicotine Delivery Systems
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Terminated |
NCT03517111 -
The Impact of a Parenting Intervention on Latino Youth Health Behaviors
|
N/A | |
Completed |
NCT04562467 -
The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk
|
Phase 4 | |
Completed |
NCT03429920 -
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
|
N/A | |
Completed |
NCT04551872 -
RESILIENCE: Personalizing Cardiovascular Health
|
N/A | |
Enrolling by invitation |
NCT03314818 -
Natural History of Carotid Plaque as Determined by 3D Ultrasound
|
N/A | |
Completed |
NCT03060811 -
Mediterranean Diet, Trimethylamine N-oxide (TMAO) and Anti-oxidants in Healthy Adults
|
N/A | |
Completed |
NCT04279704 -
Overcoming Obstacles in Epigenetic Analysis of Human Twins
|
||
Completed |
NCT01050205 -
The Healthy Lifestyle Project
|
N/A | |
Completed |
NCT03570840 -
Pediatric Metabolic Syndrome Study
|
||
Completed |
NCT03039023 -
Effects of Choline From Eggs vs. Supplements on the Generation of TMAO in Humans
|
N/A | |
Completed |
NCT03646175 -
Choline Supplementation and Cardiovascular Health
|
N/A |